We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Servision | LSE:SEV | London | Ordinary Share | GB00B0586C20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.85 | 0.70 | 1.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/8/2014 12:56 | Took the hit here Stig. Luckily enough just bought QPP for first time ever at 142.5p should get losses back there. | 21trader | |
06/8/2014 12:55 | As Bjork would say it's oh so quiet | the stigologist | |
04/8/2014 15:41 | he would have 0.03% then | the stigologist | |
04/8/2014 15:29 | Perhaps Gabriel Sassoon is TopInfo? | loverat | |
04/8/2014 12:59 | it can just wondering exactly who he is that's all if it's him he has no investment background so nothing to get excited about | euclid5 | |
04/8/2014 10:57 | Anybody can invest euclid so why can it not be him ? | 21trader | |
04/8/2014 10:56 | 21 trader - your link to the person is just a Political consultant not an investor - tricky one here because they don't specify any further info either way he muct be one of the placing holders & invested £295,000 | euclid5 | |
04/8/2014 10:54 | Is the Company still trading despite being technically insolvent ? | the stigologist | |
04/8/2014 10:53 | Unless of course Gabriel Sassoon in Israel is the same as Paul Smith in the uk :-)) | 21trader | |
04/8/2014 10:52 | Is this our investor - can't seem to find other investors with the same name hxxps://www.linkedin | euclid5 | |
04/8/2014 10:47 | Not sure if it is the same person after having done a bit of research myself. Either way, shows confidence in the company. | bill182 | |
04/8/2014 10:44 | Interesting if the same person and did he pay over 5p for the stock in the premium placing ? | 21trader | |
04/8/2014 10:33 | should go lower now | the stigologist | |
04/8/2014 10:30 | TIDMSEV RNS Number : 1539O SerVision plc 04 August 2014 SerVision PLC ("SerVision" or the "Company") Holding in Company SerVision (AIM: SEV), the AIM quoted developer and manufacturer of digital security systems, announces that it received notification on 1 August 2014 from Gabriel Sassoon that he holds 5,660,935 ordinary shares of 1 pence each in the Company representing 8.25% of the current issued share capital of the Company. -ends- | topinfo | |
03/8/2014 22:13 | Mobileye Record IPO Defeats Global Selloff as Shares Soar Mobileye NV (MBLY), which makes software to avoid car accidents, overcame the worst global stock-market selloff in almost five months to raise $890 million last week, a record for an Israeli company going public in the U.S. The shares soared 48 percent to $37 in New York on their first day of trading on Aug. 1 after the company and existing shareholders sold 35.6 million shares for $25 each, according to a Mobileye statement. That was above the high end of the $21 to $23 marketed range. The Jerusalem-based company weathered the biggest rout in global equities since March and a weekly drop of 1.8 percent in the Bloomberg Israel-US Equity Index. Mobileye commanded more money from investors while only three of four Israeli biotechnology firms completed planned initial public offerings last week, with all either downsizing or pricing below their target range. "Some of these IPOs which are in special industries are trading in their own world," Josef Schuster, the founder of IPOX Schuster LLC in Chicago, said by phone Aug. 1. "In the last week or two you have seen some of the IPO stocks really trading independently of the market." Sharron Silvers, a New York-based spokeswoman for Mobileye, declined via e-mail to comment on the trading. The company, which counts luxury electric-carmaker Tesla Motors Inc. as a customer, posted 2013 net income of $19.9 million following two years of losses, according to the prospectus. Revenue in 2013 was $81.2 million, more than double the figure from 2012. Revenue Growth Mobileye rallied after boosting its deal because investors see it as a high-growth technology company with proven sales within the auto industry, said Brian Krawez, who oversees $3 billion at Scotts Valley, California-based Scharf Investments LLC. "A lot of tech companies that don't make a lot of money such as Mobileye and Tesla that have high revenue growth, tend to get really high valuations," Krawez said by phone Aug. 1. "To justify this valuation, the company has to hit a huge home run." The MSCI All-Country World Index slid 2.4 percent last week as Mobileye completed its stock offering. Stocks tumbled after companies from Exxon Mobil Corp. to Samsung Electronics Co. reported results that disappointed investors, Argentina defaulted and Banco Espirito Santo SA in Portugal was ordered to raise capital. Israel's TA-25 benchmark slipped 0.4 percent in the five days ended July 31 as fighting between Israel and Hamas continued. The gauge closed little changed at 1,392.98 in Tel Aviv yesterday. Biotech IPOs Mapi Pharma Ltd. (MAPI), which makes treatments for multiple sclerosis, postponed plans to raise $18 million in an IPO last week, according to data compiled by Bloomberg. Vascular Biogenics Ltd., which develops cancer drugs, raised $64.8 million, selling 5.4 million shares for $12 a share, below the marketed price range of $13 to $15, according to a regulatory filing. MacroCure Ltd. (MCUR) and Bio Blast Pharma Ltd. also raised less than planned. "There's a difference between a hot market where you can do anything, and a smart market that says, is there a catalyst behind this, is there an unmet medical need?" Jason Kolbert, an analyst at Maxim Group LLC in New York, said by phone Aug. 1. "The market is beginning to differentiate between just anything, which is where we were in January to March, to selective." Mobileye's IPO was the 10th-largest in the U.S. this year and surpassed Partner Communication Ltd.'s share sale of $525 million in October 1999 to become the biggest by an Israeli company in the U.S. Mobileye Founders Founded by Hebrew University professor Amnon Shashua and Ziv Aviram 15 years ago, Mobileye makes a chip and a system that alert drivers to pedestrians and unintended lane departures. The company's products will help enable hands-free driving on the highway by 2016, according to the filing. As of March 31, Mobileye's technology was installed in about 3.3 million cars made by manufacturers from Honda Motor Co. to Tesla, the company estimates. Mobileye's software is distributed through auto-parts suppliers such as TRW Automotive Holdings Corp. (TRW) and Delphi Automotive Plc. The record deal size represents a new wave of Israeli startups that are turning down strategic partnerships and acquisition offers to grow independently, said Adam Fisher, a partner in the Herzliya, Israel-based office of Bessemer Venture Partners. "The companies we back seem to be more ambitious than ever before, much bigger markets, they don't sell out as early," Fisher, who isn't an investor in Mobileye, said by phone on July 28. "It's a new breed of Israeli tech that's different from the tech of the 90's." hxxp://www.bloomberg | euclid5 | |
03/8/2014 17:04 | Interesting comments here. Not a great macroeconomic or socio-demographic backdrop for Israeli companies like SEV and PTV Zionists have to maintain the pretence that "democratic ideals are integral to Zionism", but the quest to produce even an image of Democratic Zionism has directly led to the unwinding of Israel. Israel of today is multicultural and multi-ethnic. More than 20% of its population is not Jewish. Israel is in fact a typical western-type crony capitalist society with vast extremes of wealth and massive social injustice between Jews or anybody else. Zionism only exacerbates these already-dangerous fissures in society by its absurd, as well as absurdly unjust and brutal treatment of Palestinians. Sooner or later, the continuing call by unrepentant Zionists for more and further expansion and colonization will have to end. One simple reason for this count-down is that taking more land, with the people on it, and bringing them into a democratic Israel where people can vote will only, and can only, further dilute and erode the 1897-era or 1948-era image of "Israel's moral foundation". Plenty of Israelis, whether Zionist or not, say the Jewish Homeland will be forced to choose between being Jewish or remaining democratic. Unsurprisingly but tragically, diehard defenders of Zionism like Michael B. Oren say that "Failure is the price of sovereignty". They say that Israeli statehood means making hard choices which can end in failure. They say that the Jewish state is always threatened by annihilation. They say the war footing must be permanent and Palestinians are ungrateful, devious and cannot be trusted. They say America will always be there to understand and help. They conclude that Israeli statehood and sovereignty may be a mess but it is Our Zionist Mess. There is no alternative. So much for Zionism. By Andrew McKillop Contact: xtran9@gmail.com Former chief policy analyst, Division A Policy, DG XVII Energy, European Commission. Andrew McKillop Biographic Highlights Co-author 'The Doomsday Machine', Palgrave Macmillan USA, 2012 Andrew McKillop has more than 30 years experience in the energy, economic and finance domains. Trained at London UK's University College, he has had specially long experience of energy policy, project administration and the development and financing of alternate energy. This included his role of in-house Expert on Policy and Programming at the DG XVII-Energy of the European Commission, Director of Information of the OAPEC technology transfer subsidiary, AREC and researcher for UN agencies including the ILO. | the stigologist | |
01/8/2014 14:50 | I have made quite a bit of money out of these companies in the past. Most gone down the plughole but you bank your profit while they are trading. | loverat | |
01/8/2014 14:48 | Company is another one of these dodgy Israeli companies which manages to carry on trading despite being technically insolvent | the stigologist | |
01/8/2014 14:37 | lolz reckon same applies to foreign israeli companies on AIM as well... http://www.moneyweek Why I don't buy Chinese stocks on AIM By Tom Bulford Sep 18, 2012 Greg Rudd, the brother of the former Australian prime minister, once met a Chinese businessman who gave him some prudent advice. "You tend to see the good in people, Mr Rudd", he started. "People like you. You laugh a lot. But you'll never make money in China with that attitude. You'll only be taken advantage of. People will trade off you. They won't pay you. The number one rule of doing business in China is this; never trust a Chinaman. Why would you as a foreigner trust a Chinese businessman when we as Chinese don't trust each other?" Now that advice is pretty close to the bone. But I've said it before in Penny Sleuth you have to be very careful when you invest in a Chinese company. The record of AIM-listed Chinese companies is simply awful. And with so many still coming to market, there is a real chance that many private investors will end up making some very expensive mistakes... | the stigologist | |
01/8/2014 14:35 | The time to buy these I reckon is around about now. Investors paid 5.2p just a while ago and this has fallen back again. Have bought some and might pick some up more if the share price falls anymore. | loverat | |
31/7/2014 11:32 | Indeed he is. | loverat | |
31/7/2014 11:32 | From listening to the interview with the CEO, I don't think we will have to wait long before the next contract win news. This is a long term hold for me, and I fully expect to see a significant appreciation in the share price over the coming months. Don't know, or care what Stocky is saying as I have him on filter from another thread. If he is de-ramping the share, then that is good news as he is more often that not totally wrong. | bill182 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions